Dipyridoxyl phosphate NMRI contrast agents

Details Dipyridoxyl phosphate NMRI contrast agents Dipyridoxyl phosphate NMRI contrast agents

1987-05-08

1990-06-12

Rotman, Alan L.

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

544109, 424 11, 546 24, 546261, C07F 102, C07F 304, C07F 1300, C07F 958

Patent

active

049334565

ABSTRACT:
N,N'-bis-(pyridoxal-5-phosphate)-alkylenediamine-N,N'-diacetic acids, N,N'-bis-(pyridoxal-5-phosphate)-1,2-cycloalkylenediamine-N,N'-diacetic acids, and N,N'-bis-(pyridoxal-5-phosphate)-1,2-arylenediamine-N,N'-diacetic acids, the corresponding monophosphate compounds and monoacetic acid compounds, and their salts and esters form stable, highly soluble chelates with paramagnetic metal ions, and are highly effective NMRI contrast agents. Preferred contrast agents are paramagnetic ion chelates of N,N'-bis-(pyridoxal-5-phosphate)ethylene-diamine-N,N'-diacetic acid, N,N'-bis-(pyridoxal-5-phosphate)trans-1,2-cyclohexylenediamine-N,N'-diacet ic acid, N,N'-bis-(pyridoxal-5-phosphate)trans-1,2-arylenediamine-N,N'-diacetic acid, and the soluble calcium salts thereof.
Novel intermediates for forming these compounds are N,N'-bis(pyridoxal-5-phosphate)alkylenediimines, N,N'-bis(pyridoxal-5-phosphate)alkylenediamines, N,N'-bis(pyridoxal-5-phosphate)-1,2-cycloalkylenediimines, N,N'-bis(pyridoxal-5-phosphate)-1,2-cycloalkylenediamines, N,N'-bis(pyridoxal-5-phosphate(-1,2-arylenediamines, and the corresponding monophosphate compounds.

REFERENCES:
patent: 3632637 (1972-01-01), Martel
patent: 3981980 (1976-09-01), Baker et al.
patent: 4313928 (1982-02-01), Kato et al.
patent: 4440739 (1984-04-01), Azuma et al.
patent: 4489053 (1984-12-01), Azuma et al.
patent: 4637929 (1987-01-01), Quay
patent: 4647447 (1987-03-01), Gries et al.
patent: 4842845 (1989-06-01), Rocklage et al.
Taliaferro, C. et al.; "New Multidentate Ligands. 22. et seq."; Inorg. Chem. 23:1188-1192 (1984).
Taliaferro, C. et al.; "NMR Investigation of Protonation Sites et seq."; Inorg. Chem.; 24:2408-2413 (1985).
Green, M. et al.; "Evaluation of PLED as a Chelating Ligand et seq."; Int. J. Nucl. Mec. Biol.; 12(5):381-386 (1985).
Frost et al.; "Chelating Tendencies of N,N'-Ethylenebis-et seq."; J. Am. Chem. Soc.; 80:530 (1958).
Anderegg, G. et al.; "117. Metallindikatoren VII. et seq"; 47:1067 (1964)--foreign language--.
L'Eplattenier, F. et al., "New Multidentate Ligands. et seq"; J. Am. Chem. Soc.; 89:837 (1967).
Patch et al., "The Cobalt (III), Chromium (III), Copper (II), and Manganese (III) Complexes et seq."; Inorg. Chem 21(8):2972-2977 (1982).
Rocklage et al.; "Manganese (II) N,N'-Dipyridoxylethylenediamine-N,N'-et seq"; Inorganic Chemistry; 1989, 2,477.

Affiliated with

Also associated with

Rating

Dipyridoxyl phosphate NMRI contrast agents does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Dipyridoxyl phosphate NMRI contrast agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dipyridoxyl phosphate NMRI contrast agents will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-618083